For: | Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i43/7462.htm |
Number | Citing Articles |
1 |
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
|
2 |
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences 2022; 308: 120974 doi: 10.1016/j.lfs.2022.120974
|
3 |
Guorong Jia, Tao Wang, Rou Li, Xiao Li, Gaofeng Sun, Wei Chen, Ye Peng, Chao Cheng, Jijin Yang, Changjing Zuo. Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Advanced Healthcare Materials 2023; 12(32) doi: 10.1002/adhm.202301559
|
4 |
Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng. Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma. Cancers 2023; 15(4): 1005 doi: 10.3390/cancers15041005
|
5 |
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
|
6 |
Ronald S. Arellano. Complications Associated with Image-Guided Percutaneous Thermal Ablation of Liver Tumors. Digestive Disease Interventions 2023; 7(03): 180 doi: 10.1055/s-0042-1760372
|
7 |
Pan Liu, Xu Zhang, Qiang Fu, ChuanJiang Liu, QianKun Luo, PengFei Yu, Song Chen, HongWei Zhang, Tao Qin, Yuanwei Zhang. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/9313680
|
8 |
Kassem Sharif, Adi Lahat, Idan Levy, Shomron Ben Horin. Gastric Perforation After Microwave Ablation to Adjacent Hepatocellular Lesion. ACG Case Reports Journal 2023; 10(6): e01082 doi: 10.14309/crj.0000000000001082
|
9 |
John Domini, Mina S. Makary. Single-center analysis of percutaneous ablation in the treatment of hepatocellular carcinoma: long-term outcomes of a 7-year experience. Abdominal Radiology 2023; doi: 10.1007/s00261-023-03819-y
|
10 |
Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. Journal of Hepatocellular Carcinoma 2023; : 2021 doi: 10.2147/JHC.S407680
|
11 |
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Yingmin Yao, Wen Sun, Qiancheng Ma, Dongsheng Huang, Qiuran Xu. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. Biochemical and Biophysical Research Communications 2023; 638: 210 doi: 10.1016/j.bbrc.2022.11.046
|
12 |
Lauren Matevish, Madhukar S. Patel, Parsia A. Vagefi. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation. Surgical Clinics of North America 2024; 104(1): 145 doi: 10.1016/j.suc.2023.07.004
|
13 |
Attila Kovács, Peter Bischoff, Hathal Haddad, Willi Zhou, Susanne Temming, Andreas Schäfer, Hannah Spallek, Lucas Kaupe, György Kovács, Michael Pinkawa. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. Journal of Personalized Medicine 2022; 12(3): 430 doi: 10.3390/jpm12030430
|
14 |
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives. Cancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
|
15 |
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
|
16 |
Piaoyi Chen, Qinglin Xiao, Zhaoxiong Guo, Wei Liang, Ou Liu, Liteng Lin, Yugang Huang, Kangshun Zhu, Guodong Ye. Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped Fe3O4@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imaging. Biomedical Materials 2024; 19(3): 035011 doi: 10.1088/1748-605X/ad2c1a
|
17 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
18 |
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton, Fabio Tucci, Satheesh Ravula, David K. Imagawa. Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model. Cancers 2023; 15(12): 3236 doi: 10.3390/cancers15123236
|
19 |
Sarah B. White, Dilip Rajasekhar Maddirela. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3: 255 doi: 10.1007/16833_2022_122
|
20 |
Josua A. Decker, Christian Scheurig-Muenkler, Jan H. Luitjens, Thomas Kroencke. Nationwide Trends and the Influence of Age and Gender in the In-Patient Care of Patients with Hepatocellular Carcinoma in Germany between 2010 and 2020. Cancers 2023; 15(10): 2792 doi: 10.3390/cancers15102792
|
21 |
Andrei M. Jipa, Mina S. Makary. Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications. Cancers 2024; 16(7): 1271 doi: 10.3390/cancers16071271
|
22 |
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine 2022; : 909 doi: 10.2147/IJN.S349426
|